Skip to main content
. 2020 Oct;9(5):1406–1414. doi: 10.21037/gs-20-225

Table 5. Flap and systemic complications.

Variable TIVA group (n=31) Sevo group (n=52) P value
Flap compromise 2 (6.5%) 5 (9.6%) 0.707
Flap arterial thrombosis 0 (0.0%) 0 (0.0%) 1.000
Flap venous thrombosis 1 (3.2%) 0 (0.0%) 0.373
Mechanical obstruction 1 (3.2%) 5 (9.6%) 0.403
Partial flap loss 0 (0.0%) 0 (0.0%) 1.000
Total flap loss 1 (3.2%) 0 (0.0%) 0.373
Wound infection 0 (0.0%) 1 (1.9%) 1.000
Delayed wound healing 0 (0.0%) 1 (1.9%) 1.000
Wound breakdown 0 (0.0%) 0 (0.0%) 1.000
Systemic complications 0 (0.0%) 1 (1.9%) 1.000

Systemic complications included deep vein thrombosis, pulmonary embolism, stroke, arrhythmia, myocardial infarction, pleural effusion, pneumonia, renal insufficiency, and others. TIVA, total intravenous anesthesia; Sevo, sevoflurane.